提醒

Microbot Medical Inc. (MBOT)

NasdaqCM: MBOT · 即時價格 · USD

1.48

-0.02 (-1.33%)

收盤價： Aug 28, 2026, 3:59 PM

股價、關鍵數字和最新消息，都在這一頁。

-1.33% (1D)

買價	1.46
市值	99.4M
營收 (ttm)	346K
淨利（ttm）	-16.34M
	1.05
	-0.25
	n/a
	-4.31
P/B (ttm)	1.44
P/S (ttm)	287.27
財報日期	n/a

賣價	1.9
成交量	467,428
20 日平均成交量	780,219
開盤價	1.50
前收盤價	1.50
當日區間	1.46 - 1.51
52 週範圍	1.44 - 4.67
分析師	Strong Buy
目標價	4 (170.27%)
股利	n/a
除息日	n/a

關於 MBOT

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. I...

[閱讀更多]

產業 Medical Devices

類股 Healthcare

IPO 日期 Mar 25, 1992

員工 43

證券交易所 NasdaqCM

股票代號 MBOT

網站 https://microbotmedical.com

完整的公司簡介

財務表現

Microbot Medical 在 2025 年的營收為 0，較前一年的 0 增加 undefined%。淨利為 -13.14M，較前期增加 14.85%。

財務報表

分析師預測

根據 3 位分析師的評等，MBOT 的平均評等為「Strong Buy」。12 個月目標價為 4，較最新價格有 170.27% 的上漲空間。

股票預測

財報驚奇

Microbot Medical 已於 Aug 11, 2026 公布季度財報：

營收為 $105K 低於預期 $0, 年增 Infinity% 成長.
每股盈餘為 -0.08 低於預期 0.00, 年增 20.00% 成長.

新聞動態

2 週前 · Zacks

Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates

Microbot Medical (MBOT) delivered earnings and revenue surprises of 0.00% and -22.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

2 月前 · StockStory

Why Is Sanmina (SANM) Stock Soaring Today

Shares of electronics manufacturing services company Sanmina (NASDAQ:SANM) jumped 5.4% in the afternoon session after Microbot Medical selected it as a manufacturing partner for its LIBERTY® Endovascu...

3 月前 · Zacks

After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)

Microbot Medical (MBOT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings es...

3 月前 · Simply Wall St.

Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

3 月前 · Zacks

Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates

Microbot Medical (MBOT) delivered earnings and revenue surprises of +37.50% and -76.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

第 1 頁，共 2 頁

Microbot Medical Inc. (MBOT)